반응식
[CH3:1][C:2]1[NH:6][N:5]=[C:4]([C:7]([OH:9])=O)[N:3]=1.CCN=C=NCCCN(C)C.Cl.C1C=CC2N(O)N=NC=2C=1.[C:32]([C:36]1[CH:45]=[CH:44][C:39]([C:40](=[NH:43])[NH:41]O)=[CH:38][CH:37]=1)([CH3:35])([CH3:34])[CH3:33]>CN(C=O)C.O.CCOC(C)=O>[C:32]([C:36]1[CH:45]=[CH:44][C:39]([C:40]2[N:41]=[C:7]([C:4]3[N:3]=[C:2]([CH3:1])[NH:6][N:5]=3)[O:9][N:43]=2)=[CH:38][CH:37]=1)([CH3:35])([CH3:33])[CH3:34]참가 물질
반응물 4
생성물 1
시약·촉매·용매 3
실험 절차
5-Methyl-1H-1,2,4-triazole-3-carboxylic acid (200 mg, 1.57 mmol), EDC.HCl (360 mg, 1.89 mmol), and HOBT (255 mg, 1.89 mmol) were dissolved in DMF (15 mL) and the solution was stirred at RT for 30 min. 4-(tert-Butyl)-N-hydroxybenzimidamide (363 mg, 1.89 mmol) was added and the reaction was stirred at RT for 1 h and then at 140° C. for an additional 2 h. The reaction mixture was cooled to RT, and diluted with H2O (100 mL) and EtOAc (100 mL). The organic layer was separated, washed with H2O (2×50 mL) and brine (25 mL), dried over Na2SO4, filtered, and concentrated to afford the crude product which was purified by silica gel chromatography (EtOAc/Hexane 12%-100% EtOAc) to afford 3-(4-(tert-butyl)phenyl)-5-(5-methyl-1H-1,2,4-triazol-3-yl)-1,2,4-oxadiazole as a yellow solid (210 mg, 47%). MS (ES+) C15H17N5O requires: 283. found 284 [M+H]+; 1H NMR (600 MHz, CDCl3) δ 8.02 (d, J=8.4 Hz, 2H), 7.63 (d, J=8.4 Hz, 2H), 2.50 (s, 3H), 1.34 (s, 9H).
후처리
- stirringthe reaction was stirred at RT for 1 h
- waitat 140° C. for an additional 2 h
- temperatureThe reaction mixture was cooled to RT
- customThe organic layer was separated
- washwashed with H2O (2×50 mL) and brine (25 mL)
- dry with materialdried over Na2SO4
- filtrationfiltered
- concentrationconcentrated
- customto afford the crude product which
- customwas purified by silica gel chromatography (EtOAc/Hexane 12%-100% EtOAc)
출처 및 근거
- ORD 기록
- ord-4a89d5b11a97450fb4609fccd79da53f
- 출처 데이터셋
- uspto-grants-2015_04
- 특허 번호
- US09018380B2
연결된 노트
불러오는 중…